165 related articles for article (PubMed ID: 14747843)
1. The pharmaceutical industry and research in 2002 and beyond.
Dutta AS; Garner A
Drug News Perspect; 2003 Dec; 16(10):637-48. PubMed ID: 14747843
[TBL] [Abstract][Full Text] [Related]
2. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
3. The lost science of formulation.
Brown MB
Drug Discov Today; 2005 Nov; 10(21):1405-7. PubMed ID: 16243254
[No Abstract] [Full Text] [Related]
4. Lessons from 54 years of pharmaceutical research.
Firestone RA
Nat Rev Drug Discov; 2011 Oct; 10(12):963. PubMed ID: 22036986
[No Abstract] [Full Text] [Related]
5. Deal watch: Trends in platform technology deal-making.
Walker J; Jacob J
Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
[No Abstract] [Full Text] [Related]
6. A lesson from Japan: research and development efficiency is a key element of pharmaceutical industry consolidation process.
Shimura H; Masuda S; Kimura H
Drug Discov Ther; 2014 Feb; 8(1):57-63. PubMed ID: 24647159
[TBL] [Abstract][Full Text] [Related]
7. Decline in economic returns from new drugs raises questions about sustaining innovations.
Berndt ER; Nass D; Kleinrock M; Aitken M
Health Aff (Millwood); 2015 Feb; 34(2):245-52. PubMed ID: 25646104
[TBL] [Abstract][Full Text] [Related]
8. Fewer new drugs from the pharmaceutical industry.
Taylor D
BMJ; 2003 Feb; 326(7386):408-9. PubMed ID: 12595352
[No Abstract] [Full Text] [Related]
9. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
10. The state of innovation in drug development.
Kola I
Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
[TBL] [Abstract][Full Text] [Related]
11. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M
J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721
[TBL] [Abstract][Full Text] [Related]
12. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
13. What should be done to improve the productivity of neurological research?
Moses H; Martin JB
Ann Neurol; 2006 Dec; 60(6):647-51. PubMed ID: 17192925
[No Abstract] [Full Text] [Related]
14. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
[TBL] [Abstract][Full Text] [Related]
15. [Current challenges for the pharmaceutical research industry].
Chalchat B
Ann Pharm Fr; 1993; 51(1):16-25. PubMed ID: 8215118
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial drug discovery: is it all downhill from here?
Projan SJ; Shlaes DM
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036
[TBL] [Abstract][Full Text] [Related]
17. The abandonment of antibacterials: why and wherefore?
Shlaes DM
Curr Opin Pharmacol; 2003 Oct; 3(5):470-3. PubMed ID: 14559090
[TBL] [Abstract][Full Text] [Related]
18. Drug discovery alliances.
Jones A; Clifford L
Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845
[No Abstract] [Full Text] [Related]
19. Compound scale-up at the discovery-development interface.
Nikitenko AA
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):729-40. PubMed ID: 17117683
[TBL] [Abstract][Full Text] [Related]
20. Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics.
Fitzgerald GA
Nat Rev Drug Discov; 2005 Oct; 4(10):815-8. PubMed ID: 16224453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]